2-Methylaminobenzoic Acid Methyl Ester

2-Methylaminobenzoic Acid Methyl Ester

SCHEMBL29991762

CN(C)c1ccccc1C(=O)O.CNc1ccccc1C(=O)OC

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.69
▸ POLB P06746 1/20 0.69
▸ ATM Q13315 1/20 0.69
▸ MAPT P10636 3/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ GAA P10253 6/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ KMT2A Q03164 4/20 0.48
▸ TSHR P16473 5/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ HSD17B10 Q99714 4/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HTT P42858 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ MEN1 O00255 1/20 0.44
▸ MAPK10 P53779 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Methylaminobenzoic Acid Methyl Ester SCHEMBL29364831 0.83 KDM4E (1.00) KDM4EPOLBATMMAPTALOX15
2-Methylaminobenzoic Acid Methyl Ester SCHEMBL165559 0.83 KDM4E (1.00) KDM4EPOLBATMMAPTALOX15
Methyl Anthranilate SCHEMBL30229574 0.81 ALDH1A1 (0.68) KDM4EPOLBATMMAPTALOX15
SCHEMBL43644 0.81 KMT2A (0.67) KDM4EPOLBATMMAPTALOX15
2-Methylaminobenzoic Acid Methyl Ester SCHEMBL29271837 0.81 KDM4E (0.96) KDM4EPOLBATMMAPTALOX15
SCHEMBL29408467 0.81 KMT2A (0.67) KDM4EPOLBATMMAPTALOX15
2-Methylaminobenzoic Acid Methyl Ester SCHEMBL18954209 0.80 KDM4E (0.80) KDM4EPOLBATMMAPTALOX15
2-Methylaminobenzoic Acid Methyl Ester SCHEMBL1868040 0.79 KDM4E (0.73) KDM4EPOLBATMMAPTALOX15
SCHEMBL15240 0.79 ALDH1A1 (0.72) KDM4EPOLBMAPTALOX15GAA
Phthalic Acid SCHEMBL25407447 0.78 ALDH1A1 (0.69) KDM4EPOLBMAPTALOX15GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240206778-A1 FRAGRANCE FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2024-06-27 — — US claimed
US-20240197183-A1 ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2024-06-20 — — US claimed
US-20240197221-A1 FRAGRANCE FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2024-06-20 — — US claimed
US-20240173230-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2024-05-30 — — US claimed
EP-4347761-A1 ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING Givaudan SA (CH) 2024-04-10 — — EP claimed
EP-4347762-A1 FRAGRANCE FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING Givaudan SA (CH) 2024-04-10 — — EP claimed
EP-4347758-A1 FRAGRANCE FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING Givaudan SA (CH) 2024-04-10 — — EP claimed
EP-4319715-A1 FRAGRANCE COMPOSITION Givaudan SA (CH) 2024-02-14 — — EP claimed
CN-117480236-A Perfume for improving state of agitation and evaluation method 奇华顿股份有限公司 2024-01-30 — — CN claimed
CN-117396588-A Oral care flavor and assessment method for improving state of agitation 奇华顿股份有限公司 2024-01-12 — — CN claimed
CN-117396591-A Fragrance and evaluation method for improving happy state 奇华顿股份有限公司 2024-01-12 — — CN claimed
WO-2022234150-A1 FRAGRANCE FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2022-11-10 — — WO claimed
WO-2022234151-A1 FRAGRANCE FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2022-11-10 — — WO claimed
WO-2022234154-A1 ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2022-11-10 — — WO claimed
WO-2022214636-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2022-10-13 — — WO claimed
US-20240206778-A1 FRAGRANCE FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2024-06-27 — — US disclosed
US-20240197222-A1 ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2024-06-20 — — US disclosed
WO-2022234153-A1 ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2022-11-10 — — WO disclosed
WO-2022234152-A1 ORAL CARE FLAVOUR FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2022-11-10 — — WO disclosed
WO-2022214636-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2022-10-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240173230-A1 FRAGRANCE COMPOSITION FABP2, FABP5, FAAH2 KDM4E 2086/4885POLB 766/4885ATM 4291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback